Peak6 Investments LLC Sage Therapeutics, Inc. Call Options Transaction History

Peak6 Investments LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 12, 2023	SELL	$37.27 - $46.57 $2.88 Million - $3.6 Million	-77,200 Reduced 91.15%	7,500 $314,000
Q4 2022 Feb 10, 2023	SELL	$32.2 - $43.61 $463,680 - $627,984	-14,400 Reduced 14.53%	84,700 $3.23 Million
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $3.2 Million - $4.29 Million	99,100 New	99,100 $3.88 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.